Update on NAV and Anthropic valuation

Summary by AI ^BETAClose X

Baillie Gifford US Growth Trust PLC announced an upward adjustment to the valuation of its holding in Anthropic, which has increased the Company's Net Asset Value to 324.18p as of April 24, 2026. This revaluation has significantly raised Anthropic's proportion of the Company's total assets to 7.4% from 3.3% as of March 31, 2026.

Disclaimer*

Baillie Gifford US Growth Trust PLC

27 April 2026

This announcement contains inside information for the purposes of Article 7 of the UK Market Abuse Regulation. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Baillie Gifford US Growth Trust plc ('USA')

Legal Entity Identifier: 213800UM1OUWXZPKE539

Update on Net Asset Value and adjustment to the valuation of Anthropic

Today, the Board has been advised by the Manager of an upwards adjustment in the valuation of the Company's holding in Anthropic in line with its policy for valuing private company investments. This has been reflected in the Net Asset Value of the Company which as at close of business on 24 April 2026 stands at 324.18p.

Following that adjustment in valuation the proportion of the Company's total assets made up by Anthropic stands at 7.4% at close of business on 24 April 2026, compared with 3.3% on 31 March 2026.

Baillie Gifford & Co Limited

Company Secretaries

27 April 2026

Regulated Information Classification: Additional regulated information required to be disclosed under applicable laws and regulations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END